Concepedia

Fabienne Lebrun

FL

Statistics

Publications

22

Citations

4.4K

H-Index

16

Active since

1990

Affiliations

Institut Jules Bordet(Current)

Université Libre de Bruxelles

Inserm

UCSF Helen Diller Family Comprehensive Cancer Center

Novartis (Switzerland)

Fabienne Lebrun is an author at Institut Jules Bordet specializing in medicine, oncology, and pharmacology.

Publications per year

1990–2016

22

Publications

22

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

José Baselga, Mario Campone, Martine Piccart et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

, , +9

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

Martine Piccart, Gabriel N. Hortobágyi, Mario Campone et al. · Annals of Oncology · 2014 · 568 citations · Full text

, , +12

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From BOLERO-2

Gabriel N. Hortobágyi, David Chen, Martine Piccart et al. · Journal of Clinical Oncology · 2015 · 246 citations · Full text

, , +17

AKT1 Inhibits Homologous Recombination by Inducing Cytoplasmic Retention of BRCA1 and RAD51

Isabelle Plo, Corentin Laulier, Laurent Gauthier et al. · Cancer Research · 2008 · 131 citations

, , +17

Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial

Howard A. Burris, Fabienne Lebrun, Hope S. Rugo et al. · Cancer · 2013 · 100 citations · Full text

, , +15

1–5 of 22